Disclosures: Alexander Yang: Nothing to Disclose, Monica Tincopa: Nothing to Disclose, Federica Tavaglione: Nothing to Disclose, Veeral Ajmera: Nothing to Disclose, Lisa Richards: Nothing to Disclose, Maral Amangurbanova: Nothing to Disclose, Christian Butcher: Nothing to Disclose, Christie Hernandez: Nothing to Disclose, Egbert Madamba: Nothing to Disclose, Seema Singh: Nothing to Disclose, Ricki Bettencourt: Nothing to Disclose, Bernd Schnabl: Mabwell Therapeutics: Consultant, Ambys Medicines: Consultant, Surrozen: Consultant, Nterica Bio: Stock privately held company, Axial Biotherapeutics: Grant/Research Support, Prodigy Biotech: Grant/Research Support, CymaBay Therapeutics: Grant/Research Support, Intercept Pharmaceuticals: Grant/Research Support, ChromoLogic: Grant/Research Support, Claude Sirlin: Nothing to Disclose, Rohit Loomba: Eli Lilly and Company: Consultant 1591 THE CARE OF ACUTE ALCOHOL ASSOCIATED HEPATITIS AT A LARGE TERTIARY CARE AND LIVER TRANSPLANT CENTER: ASSESSING KNOWLEDGE GAPS Alessandro Colletta 1 Katherine Cooper 1 Deepika Devuni 1 , 1 UMass Chan Medical School Background: Acute alcohol associated hepatitis (AAH) is a clinical syndrome that occurs in patients with sustained alcohol use and has high mortality index
Tr em t 6 tui tr ln: Ung 1/2 vin/ngy vo bui sng hoc bui ti, trc hoc sau khi n
119 Treatment with TTM could prolong the survival of both presymptomatic and symptomatic SOD1 G93A mice, decrease the loss of motor neurons and attenuate the severity of skeletal muscle atrophy
10.1038/bjc.2017.96 13 HarrisI
A hard, warm lump that enlarges or becomes more painful
Doctors adjust the dose based on how the patient responds
